BCAX

Insider trade Sale by Mazumdar Claire (Chief Executive Officer)

12d ago

Insider trade Sale by Cohlhepp Ryan (President and COO)

14d ago

News Bicara plans Q3 alternative dosing study of ~150–200 patients as it targets mid-2027 interim analysis

22d ago

News Bicara Therapeutics GAAP EPS of -$0.93 misses by $0.28

22d ago

Insider trade Sale by David Raben (Chief Medical Officer)

34d ago

Insider trade Sale by Claire Mazumdar (Chief Executive Officer)

39d ago

Insider trade Sale by Ivan Hyep (Chief Financial Officer)

39d ago

Insider trade Sale by Ivan Hyep (Chief Financial Officer)

40d ago

Insider trade Sale by Claire Mazumdar (Chief Executive Officer)

42d ago

Insider trade Sale by Ryan Cohlhepp (President and COO)

45d ago

Insider trade Sale by Ivan Hyep (Chief Financial Officer)

69d ago

Insider trade Sale by Claire Mazumdar (Chief Executive Officer)

73d ago

Insider trade Sale by Ryan Cohlhepp (President and COO)

76d ago

Insider trade Sale by Claire Mazumdar (Chief Executive Officer)

87d ago

Insider trade Sale by Ryan Cohlhepp (President and COO)

88d ago

Insider trade Sale by David Raben (Chief Medical Officer)

88d ago

Insider trade Sale by Ivan Hyep (Chief Financial Officer)

88d ago

Insider trade Purchase by RA CAPITAL MANAGEMENT, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund III, L.P. / Peter Kolchinsky / Rajeev M. Shah

91d ago

Insider trade Sale by Ryan Cohlhepp (President and COO)

94d ago

News Bicara Therapeutics Announces Closing of Oversubscribed Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

95d ago

Insider trade Sale by Ryan Cohlhepp

104d ago

Insider trade Sale by Ivan Hyep

104d ago

Insider trade Sale by Ryan Cohlhepp

104d ago

Scanner Unusual volume (z=3.7)

160d ago

Scanner Unusual volume (z=3.9)

161d ago